Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)-Reference-Cited by-同舟云学术

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Published:2013-08-13 Issue:1 Volume:73 Page:48-55
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Mease P J,Fleischmann R,Deodhar A A,Wollenhaupt J,Khraishi M,Kielar D,Woltering F,Stach C,Hoepken B,Arledge T,van der Heijde D

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference34 articles.

1. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires;Haroon;Ann Rheum Dis,2013

2. Prevalence of rheumatologist-diagnosed psoriatic arthritis in psoriasis patients in European/North American dermatology clinics;Mease;J Am Acad Dermatol,2013

3. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience;Kane;Rheumatology (Oxford),2003

4. Psoriatic athritis (PA): a clinical, immunological and radiological study of 180 patients;Alonso;Rheumatology (Oxford),1991

5. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients;Austin;J Invest Dermatol,1999

Cited by 389 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment;Biomedicines;2024-08-13

4. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12

5. Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies;Expert Review of Clinical Immunology;2024-07-29